Explore a selection of our essential drug information below, or:
Identification
- Summary
Quercus alba pollen is an extract from Quercus alba pollen used in allergy testing.
- Generic Name
- Quercus alba pollen
- DrugBank Accession Number
- DB10376
- Background
Quercus alba pollen, or oak white pollen, is a non-standardized allergen extract used for the diagnosis and treatment of allergic disease to grass pollen. It can be subcutaneously administered to initiate an immune response in case of an allergic reaction. Diagnostic allergenic extracts are primarily indicated for establishing clinical relevance of specific allergens to which the patient has been exposed and the degree of sensitivity the patient has toward that allergen.
- Type
- Biotech
- Groups
- Approved
- Biologic Classification
- Allergenics
Allergen Extract - Synonyms
- Not Available
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Products
Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.- Brand Name Prescription Products
Name Dosage Strength Route Labeller Marketing Start Marketing End Region Image Center-AL - Quercus Alba Pollen Injection, suspension 10000 [PNU]/1mL Subcutaneous ALK-Abello, Inc. 1975-01-15 Not applicable US 
Quercus Alba Pollen Injection, solution 0.05 g/1mL Percutaneous ALK-Abello, Inc. 1965-01-01 Not applicable US Quercus Alba Pollen Injection, solution 0.001 g/1mL Subcutaneous ALK-Abello, Inc. 1965-01-01 2023-05-18 US Quercus Alba Pollen Injection, solution 10000 [PNU]/1mL Subcutaneous ALK-Abello, Inc. 1965-01-01 2021-11-30 US Quercus Alba Pollen Injection, solution 0.10 g/1mL Subcutaneous ALK-Abello, Inc. 1965-01-01 Not applicable US - Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image 2-oak Mix, Red/white Pollen Quercus alba pollen (0.5 g/20mL) + Quercus rubra pollen (0.5 g/20mL) Injection, solution Percutaneous; Subcutaneous Allergy Laboratories, Inc. 1967-12-07 Not applicable US 5-oak Mix, Blackjack/bur/post/red/white Pollen Quercus alba pollen (0.20 g/20mL) + Quercus macrocarpa pollen (0.20 g/20mL) + Quercus nigra pollen (0.20 g/20mL) + Quercus rubra pollen (0.20 g/20mL) + Quercus stellata pollen (0.20 g/20mL) Injection, solution Percutaneous; Subcutaneous Allergy Laboratories, Inc. 1967-12-07 Not applicable US 9 Tree Mix Quercus alba pollen (0.05 g/1mL) + Acer saccharum pollen (0.05 g/1mL) + Alnus rhombifolia pollen (0.05 g/1mL) + Betula lenta pollen (0.05 g/1mL) + Carya ovata pollen (0.05 g/1mL) + Fraxinus americana pollen (0.05 g/1mL) + Platanus occidentalis pollen (0.05 g/1mL) + Populus alba pollen (0.05 g/1mL) + Ulmus crassifolia pollen (0.05 g/1mL) Injection, solution Subcutaneous ALK-Abello, Inc. 1998-02-23 Not applicable US 9 Tree Mix Quercus alba pollen (10000 [PNU]/1mL) + Acer saccharum pollen (10000 [PNU]/1mL) + Alnus rhombifolia pollen (10000 [PNU]/1mL) + Betula lenta pollen (10000 [PNU]/1mL) + Carya ovata pollen (10000 [PNU]/1mL) + Fraxinus americana pollen (10000 [PNU]/1mL) + Platanus occidentalis pollen (10000 [PNU]/1mL) + Populus alba pollen (10000 [PNU]/1mL) + Ulmus americana pollen (10000 [PNU]/1mL) Injection, solution Subcutaneous ALK-Abello, Inc. 1975-01-15 Not applicable US 9 Tree Mix Quercus alba pollen (0.1 g/1mL) + Acer saccharinum pollen (0.1 g/1mL) + Alnus rhombifolia pollen (0.1 g/1mL) + Betula lenta whole (0.1 g/1mL) + Carya ovata pollen (0.1 g/1mL) + Fraxinus americana pollen (0.1 g/1mL) + Platanus occidentalis pollen (0.1 g/1mL) + Populus alba pollen (0.1 g/1mL) + Ulmus crassifolia pollen (0.1 g/1mL) Injection, solution Subcutaneous ALK-Abello, Inc. 1965-01-01 Not applicable US
Categories
- Drug Categories
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- Z4Y9ZSV4KK
- CAS number
- Not Available
References
Clinical Trials
- Clinical Trials
Clinical Trial & Rare Diseases Add-on Data Package
Explore 4,000+ rare diseases, orphan drugs & condition pairs, clinical trial why stopped data, & more. Preview package Phase Status Purpose Conditions Count Start Date Why Stopped 100+ additional columns Unlock 175K+ rows when you subscribe.View sample data
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Injection, solution Percutaneous; Subcutaneous Injection, solution Percutaneous Injection, solution Subcutaneous Injection, suspension Subcutaneous 10000 [PNU]/1mL Solution Intradermal; Percutaneous; Subcutaneous Injection, solution Intradermal Injection, solution Intradermal 1000 [PNU]/1mL Injection, solution Percutaneous 0.05 g/1mL Injection, solution Subcutaneous 0.001 g/1mL Injection, solution Subcutaneous 0.05 g/1mL Injection, solution Subcutaneous 0.10 g/1mL Injection, solution Subcutaneous 10000 [PNU]/1mL Injection, solution Subcutaneous 20000 [PNU]/1mL Injection, solution Subcutaneous 40000 [PNU]/1mL Injection, solution Subcutaneous 50000 [PNU]/1mL Injection, solution Intradermal; Subcutaneous Injection, solution Intradermal; Subcutaneous 0.05 g/1mL Injection, solution Intradermal; Subcutaneous 0.050 g/1mL Injection, solution Intradermal; Subcutaneous 0.1 g/1mL Injection, solution Intradermal; Subcutaneous 10000 [PNU]/1mL Injection, solution Intradermal; Subcutaneous 20000 [PNU]/1mL Injection, solution Intradermal; Subcutaneous 40000 [PNU]/1mL Injection Cutaneous; Intradermal; Subcutaneous 0.05 g/1mL Injection, solution Percutaneous; Subcutaneous 1 g/20mL Solution Intradermal; Percutaneous; Subcutaneous 0.001 g/1mL Solution Intradermal; Percutaneous; Subcutaneous 0.05 g/1mL Solution Intradermal; Percutaneous; Subcutaneous 0.1 g/1mL Solution Intradermal; Percutaneous; Subcutaneous 20000 [PNU]/1mL Solution Intradermal; Percutaneous; Subcutaneous 40000 [PNU]/1mL - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
Drug created at December 01, 2015 20:03 / Updated at June 12, 2020 16:53